Loading insider details...
Latest Form 4 (Jun 26, 2026): Grant/Award of 30,000 SPRY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 26, 2026 | ARS Pharmaceuticals, Inc. (SPRY) | Grant/Award | 30,000 | n/a |
| Jun 27, 2025 | ARS Pharmaceuticals, Inc. (SPRY) | Grant/Award | 30,000 | n/a |
| Jun 24, 2024 | ARS Pharmaceuticals, Inc. (SPRY) | Grant/Award | 40,000 | n/a |
| Jun 29, 2023 | ARS Pharmaceuticals, Inc. (SPRY) | Grant/Award | 40,000 | n/a |
| Nov 10, 2022 | ARS Pharmaceuticals, Inc. (SPRY) | Grant/Award | 3,009,677 | n/a |